HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Community-onset Staphylococcus aureus infections presenting to general practices in South-eastern Australia.

Abstract
Community-acquired Staphylococcus aureus infections are a public health concern, yet little is known about infections that do not present to hospital. We identified community-onset S. aureus infections via specimens submitted to a community-based pathology service. Referring doctors confirmed eligibility and described infection site, severity and treatment. Isolates were characterized on antibiotic resistance, PFGE, MLST/SCCmec, and Panton-Valentine leukocidin (PVL), representing 106 community-onset infections; 34 non-multiresistant methicillin-resistant S. aureus (nmMRSA) (resistant to <3 non-β-lactam antibiotics), 15 multiply antibiotic-resistant MRSA (mMRSA) and 57 methicillin-sensitive S. aureus (MSSA). Most (93%) were skin and soft tissue infections. PVL genes were carried by 42% of nmMRSA isolates [95% confidence interval (CI) 26-61] and 15% of MSSA (95% CI 8-28). PVL was associated with infections of the trunk, head or neck (56·4% vs. 24·3%, P=0·005) in younger patients (23 vs. 52 years, P<0·001), and with boils or abscesses (OR 8·67, 95% CI 2·9-26·2), suggesting underlying differences in exposure and/or pathogenesis.
AuthorsC M Bennett, G W Coombs, G M Wood, B P Howden, L E A Johnson, D White, P D R Johnson
JournalEpidemiology and infection (Epidemiol Infect) Vol. 142 Issue 3 Pg. 501-11 (Mar 2014) ISSN: 1469-4409 [Electronic] England
PMID23866772 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adult
  • Anti-Bacterial Agents (pharmacology)
  • Community-Acquired Infections (drug therapy, epidemiology, microbiology)
  • Drug Resistance, Bacterial
  • Humans
  • Methicillin-Resistant Staphylococcus aureus (isolation & purification, pathogenicity)
  • Middle Aged
  • Polymerase Chain Reaction
  • Prevalence
  • Severity of Illness Index
  • Staphylococcal Infections (drug therapy, epidemiology, microbiology)
  • Staphylococcus aureus (isolation & purification, pathogenicity)
  • Victoria (epidemiology)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: